Rare diseases
Investigational molecules
Locations
Back to Italy153 clinical trials in Messina, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of intravenous zanamivir safety and effectiveness in infants under 6 months of age with complicated influenza infection
ItalyStudy Comparing Human Normal Immunoglobulin and Placebo for Children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
ItalyStudy on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy
ItalyStudy of brivaracetam as a treatment for childhood and juvenile absence epilepsy in patients aged 2-25 years
ItalyStudy of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations
ItalyStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
ItalyStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
ItalyStudy Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ItalyComparison of nilotinib versus imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission
ItalyStudy on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease
ItalyStudy of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
ItalyStudy of Lu AG13909 in Adults with Cushing's Disease to Evaluate Safety and Effectiveness
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on hematologic malignancies and solid tumors, including studies on chronic myeloid leukemia, multiple myeloma, and lung cancer treatments.
Research emphasizes targeted therapies and immunotherapy combinations for improved patient outcomes.
Clinical studies investigating treatments for Crohn's disease, ulcerative colitis, and pyoderma gangrenosum, focusing on novel therapeutic approaches.
Emphasis on developing targeted biological therapies for chronic inflammatory conditions.
Groundbreaking research on Rett Syndrome, transthyretin amyloidosis, and polycystic kidney disease, exploring innovative treatment options.
Focus on developing targeted treatments for rare genetic conditions and improving patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
